NO870526D0 - Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.

Info

Publication number: NO870526D0
Authority: NO; Norway
Prior art keywords: dichloranilin; derivatives; procedure; preparation; therapeutic active
Prior art date: 1986-02-12

Application number

NO870526A

Other languages

English (en)

Other versions

NO170629B (no

NO870526L (no

NO170629C (no

Inventor

Henry Charles Lunts Lawrence

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-12

Filing date

1987-02-11

Publication date

1987-02-11

1987-02-11 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1987-02-11 Publication of NO870526D0 publication Critical patent/NO870526D0/no

1987-08-13 Publication of NO870526L publication Critical patent/NO870526L/no

1992-08-03 Publication of NO170629B publication Critical patent/NO170629B/no

1992-11-11 Publication of NO170629C publication Critical patent/NO170629C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO870526A 1986-02-12 1987-02-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater NO170629C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868603475A GB8603475D0 (en)	1986-02-12	1986-02-12	Chemical compounds

Publications (4)

Publication Number	Publication Date
NO870526D0 true NO870526D0 (no)	1987-02-11
NO870526L NO870526L (no)	1987-08-13
NO170629B NO170629B (no)	1992-08-03
NO170629C NO170629C (no)	1992-11-11

Family

ID=10592944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO870526A NO170629C (no)	1986-02-12	1987-02-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater

Country Status (37)

Country	Link
US (1)	US4937251A (no)
JP (2)	JPS62258359A (no)
KR (1)	KR870007886A (no)
CN (1)	CN1020095C (no)
AT (1)	AT394364B (no)
AU (1)	AU596824B2 (no)
BE (1)	BE1002129A3 (no)
CA (1)	CA1301762C (no)
CH (1)	CH670636A5 (no)
CS (1)	CS402991A3 (no)
CY (1)	CY1660A (no)
DE (1)	DE3704223C2 (no)
DK (1)	DK163991C (no)
ES (1)	ES2004676A6 (no)
FI (1)	FI83774C (no)
FR (1)	FR2596049B1 (no)
GB (2)	GB8603475D0 (no)
GR (1)	GR870220B (no)
HK (1)	HK85790A (no)
HU (1)	HU199416B (no)
IE (1)	IE59524B1 (no)
IL (2)	IL81535A (no)
IS (1)	IS1489B (no)
IT (1)	IT1205978B (no)
LU (1)	LU86768A1 (no)
MX (1)	MX5220A (no)
NL (1)	NL188408C (no)
NO (1)	NO170629C (no)
NZ (1)	NZ219241A (no)
PH (1)	PH24067A (no)
PL (1)	PL151050B1 (no)
PT (1)	PT84273B (no)
SE (1)	SE462562B (no)
SG (1)	SG70590G (no)
SU (1)	SU1590042A3 (no)
ZA (1)	ZA87974B (no)
ZW (1)	ZW2887A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8703007D0 (en) *	1987-02-10	1987-03-18	Glaxo Group Ltd	Chemical compounds
US5149698A (en) *	1987-08-11	1992-09-22	Glaxo Group Limited	Chloroaniline derivatives
GB8718939D0 (en) *	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds
DK633588A (da) *	1987-11-13	1989-05-14	Glaxo Group Ltd	Aminderivater
FI912679A (fi) *	1990-06-05	1991-12-06	Glaxo Group Ltd	Dikloranilinfoerening.
GB9104650D0 (en) *	1991-03-05	1991-04-17	Glaxo Group Ltd	Medicaments
US6419873B1 (en)	1999-03-19	2002-07-16	Q2100, Inc.	Plastic lens systems, compositions, and methods
US6436972B1 (en)	2000-04-10	2002-08-20	Dalhousie University	Pyridones and their use as modulators of serine hydrolase enzymes
TWI249515B (en)	2001-11-13	2006-02-21	Theravance Inc	Aryl aniline beta2 adrenergic receptor agonists
US7106046B2 (en) *	2002-06-18	2006-09-12	Asahi Kasei Emd Corporation	Current measuring method and current measuring device
CA2644613A1 (en) *	2006-03-07	2007-09-13	Endacea, Inc.	Compositions and methods for treating respiratory disorders
JP5626621B2 (ja)	2010-03-19	2014-11-19	株式会社日立産業制御ソリューションズ	フェイズドアレイ合成開口ソナーシステム
FI3738434T3 (fi)	2011-12-28	2023-11-20	Global Blood Therapeutics Inc	Välituotteita substituoitujen bentsaldehydiyhdisteiden saamiseksi ja menetelmiä niiden käyttöön kudosten hapetuksen lisäämiseksi
WO2013102145A1 (en)	2011-12-28	2013-07-04	Global Blood Therapeutics, Inc.	Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
KR102293060B1 (ko)	2013-03-15	2021-08-23	글로벌 블러드 테라퓨틱스, 인크.	헤모글로빈 조정을 위한 화합물 및 이의 용도
US10266551B2 (en)	2013-03-15	2019-04-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en)	2013-03-15	2014-09-18	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en)	2013-03-15	2017-03-28	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en)	2013-03-15	2018-10-16	Global Blood Therapeutics, Inc.	Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
SG11201507320QA (en)	2013-03-15	2015-10-29	Global Blood Therapeutics Inc	Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en)	2013-03-15	2017-10-31	Global Blood Therapeutics, Inc.	Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en)	2013-03-15	2016-08-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en)	2013-03-15	2015-02-10	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en)	2013-03-15	2016-10-04	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
BR112015021986A2 (pt)	2013-03-15	2017-07-18	Global Blood Therapeutics Inc	compostos e seus usos para a modulação de hemoglobina
EA202092627A1 (ru)	2013-11-18	2021-09-30	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина
FI3102208T4 (fi)	2014-02-07	2024-09-23	Global Blood Therapeutics Inc	2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi
MA41841A (fr)	2015-03-30	2018-02-06	Global Blood Therapeutics Inc	Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr)	2015-12-04	2018-10-10	Global Blood Therapeutics Inc	Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI825524B (zh)	2016-05-12	2023-12-11	美商全球血液治療公司	用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh)	2016-10-12	2023-08-16	美商全球血液治療公司	包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
ES2966707T3 (es)	2018-10-01	2024-04-23	Global Blood Therapeutics Inc	Moduladores de la hemoglobina para el tratamiento de la drepanocitosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1618005A1 (de) *	1966-09-22	1971-09-09	Thomae Gmbh Dr K	Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
NL176168C (nl) *	1972-12-18	1985-03-01	Thomae Gmbh Dr K	Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een beta2-mimetische en/of beta1-blokkerende werking bezitten.
DE2711655A1 (de) *	1977-03-17	1978-09-21	Basf Ag	Pyridinyl-aminoalkylaether
CH635320A5 (en) *	1978-01-01	1983-03-31	Ciba Geigy Ag	1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes
EP0021636B1 (en) *	1979-06-16	1982-12-01	Beecham Group Plc	Secondary amines, their preparation and use in pharmaceutical compositions
NL8105170A (nl) *	1980-12-10	1982-07-01	Thomae Gmbh Dr K	Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
US4379166A (en) *	1981-08-03	1983-04-05	Schering Corporation	Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
HU186654B (en) *	1982-12-28	1985-09-30	Richter Gedeon Vegyeszet	Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
DE3434271A1 (de) *	1984-09-19	1986-03-20	Beiersdorf Ag, 2000 Hamburg	Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8426191D0 (en) *	1984-10-17	1984-11-21	Glaxo Holdings Ltd	Chemical compounds
GB8525484D0 (en) *	1985-10-16	1985-11-20	Glaxo Group Ltd	Chemical compounds
GB8718939D0 (en) *	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds

1986
- 1986-02-12 GB GB868603475A patent/GB8603475D0/en active Pending
1987
- 1987-02-10 IS IS3193A patent/IS1489B/is unknown
- 1987-02-10 GR GR870220A patent/GR870220B/el unknown
- 1987-02-11 PT PT84273A patent/PT84273B/pt not_active IP Right Cessation
- 1987-02-11 IE IE35087A patent/IE59524B1/en not_active IP Right Cessation
- 1987-02-11 HU HU87530A patent/HU199416B/hu not_active IP Right Cessation
- 1987-02-11 PL PL1987264054A patent/PL151050B1/pl unknown
- 1987-02-11 PH PH34850A patent/PH24067A/en unknown
- 1987-02-11 SU SU874202054A patent/SU1590042A3/ru active
- 1987-02-11 IT IT47630/87A patent/IT1205978B/it active
- 1987-02-11 ZW ZW28/87A patent/ZW2887A1/xx unknown
- 1987-02-11 BE BE8700109A patent/BE1002129A3/fr not_active IP Right Cessation
- 1987-02-11 NZ NZ219241A patent/NZ219241A/en unknown
- 1987-02-11 IL IL81535A patent/IL81535A/xx not_active IP Right Cessation
- 1987-02-11 CN CN87101830A patent/CN1020095C/zh not_active Expired - Fee Related
- 1987-02-11 NO NO870526A patent/NO170629C/no unknown
- 1987-02-11 SE SE8700535A patent/SE462562B/sv not_active IP Right Cessation
- 1987-02-11 CH CH527/87A patent/CH670636A5/fr not_active IP Right Cessation
- 1987-02-11 FI FI870554A patent/FI83774C/fi not_active IP Right Cessation
- 1987-02-11 US US07/013,895 patent/US4937251A/en not_active Expired - Fee Related
- 1987-02-11 AU AU68695/87A patent/AU596824B2/en not_active Ceased
- 1987-02-11 AT AT0028687A patent/AT394364B/de not_active IP Right Cessation
- 1987-02-11 FR FR878701698A patent/FR2596049B1/fr not_active Expired - Fee Related
- 1987-02-11 DK DK069887A patent/DK163991C/da active
- 1987-02-11 GB GB8703059A patent/GB2187734B/en not_active Expired - Fee Related
- 1987-02-11 ES ES8700341A patent/ES2004676A6/es not_active Expired
- 1987-02-11 NL NLAANVRAGE8700326,A patent/NL188408C/xx not_active IP Right Cessation
- 1987-02-11 LU LU86768A patent/LU86768A1/fr unknown
- 1987-02-11 ZA ZA87974A patent/ZA87974B/xx unknown
- 1987-02-11 DE DE3704223A patent/DE3704223C2/de not_active Expired - Fee Related
- 1987-02-12 JP JP62030644A patent/JPS62258359A/ja active Granted
- 1987-02-12 MX MX522087A patent/MX5220A/es unknown
- 1987-02-12 KR KR870001162A patent/KR870007886A/ko not_active Application Discontinuation
- 1987-02-12 CA CA000529552A patent/CA1301762C/en not_active Expired - Fee Related
1989
- 1989-02-07 IL IL89205A patent/IL89205A/xx not_active IP Right Cessation
1990
- 1990-05-21 JP JP2131124A patent/JPH0314565A/ja active Pending
- 1990-08-24 SG SG705/90A patent/SG70590G/en unknown
- 1990-10-18 HK HK857/90A patent/HK85790A/xx not_active IP Right Cessation
1991
- 1991-12-23 CS CS914029A patent/CS402991A3/cs unknown
1993
- 1993-05-14 CY CY1660A patent/CY1660A/xx unknown

Also Published As

Publication number	Publication date
IT8747630A0 (it)	1987-02-11
SE462562B (sv)	1990-07-16
GB8703059D0 (en)	1987-03-18
PT84273A (en)	1987-03-01
AT394364B (de)	1992-03-25
KR870007886A (ko)	1987-09-22
FI870554A (fi)	1987-08-13
CS402991A3 (en)	1992-09-16
DK69887D0 (da)	1987-02-11
FR2596049B1 (fr)	1991-02-08
DK69887A (da)	1987-08-13
AU596824B2 (en)	1990-05-17
NL188408B (nl)	1992-01-16
FR2596049A1 (fr)	1987-09-25
CN87101830A (zh)	1987-09-09
IL81535A (en)	1990-11-05
CN1020095C (zh)	1993-03-17
IE870350L (en)	1987-08-12
PH24067A (en)	1990-03-05
HUT43566A (en)	1987-11-30
IS3193A7 (is)	1987-08-13
IE59524B1 (en)	1994-03-09
ATA28687A (de)	1991-09-15
JPH0314565A (ja)	1991-01-23
NL188408C (nl)	1992-06-16
DK163991B (da)	1992-04-27
CH670636A5 (no)	1989-06-30
ES2004676A6 (es)	1989-02-01
MX5220A (es)	1993-11-01
IS1489B (is)	1992-06-30
FI83774C (fi)	1991-08-26
US4937251A (en)	1990-06-26
IL81535A0 (en)	1987-09-16
GB8603475D0 (en)	1986-03-19
DE3704223C2 (de)	1995-05-24
SE8700535L (sv)	1987-08-13
PL151050B1 (en)	1990-07-31
FI870554A0 (fi)	1987-02-11
NL8700326A (nl)	1987-09-01
SU1590042A3 (ru)	1990-08-30
DE3704223A1 (de)	1987-08-20
GR870220B (en)	1987-05-28
GB2187734B (en)	1990-05-30
NO170629B (no)	1992-08-03
NO870526L (no)	1987-08-13
ZW2887A1 (en)	1987-09-23
BE1002129A3 (fr)	1990-07-24
SG70590G (en)	1990-10-26
FI83774B (fi)	1991-05-15
DK163991C (da)	1992-09-21
JPS62258359A (ja)	1987-11-10
NZ219241A (en)	1990-01-29
JPH0462311B2 (no)	1992-10-05
HK85790A (en)	1990-10-25
HU199416B (en)	1990-02-28
AU6869587A (en)	1987-08-13
CY1660A (en)	1993-05-14
PL264054A1 (en)	1988-10-13
NO170629C (no)	1992-11-11
PT84273B (pt)	1989-09-14
CA1301762C (en)	1992-05-26
SE8700535D0 (sv)	1987-02-11
ZA87974B (en)	1987-12-30
GB2187734A (en)	1987-09-16
IT1205978B (it)	1989-04-05
IL89205A (en)	1993-04-04
LU86768A1 (fr)	1988-03-02

Publication	Publication Date	Title
NO871266D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO883974D0 (no)	1988-09-07	Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO870526D0 (no)	1987-02-11	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871267D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO894630D0 (no)	1989-11-21	Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694D0 (no)	1990-10-30	Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO870075D0 (no)	1987-01-08	Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO901684D0 (no)	1990-04-17	Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO874869D0 (no)	1987-11-23	Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO874032L (no)	1988-03-28	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874153D0 (no)	1987-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO871588D0 (no)	1987-04-14	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO875488D0 (no)	1987-12-30	Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO871044L (no)	1987-09-15	Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891723L (no)	1989-10-30	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO864101D0 (no)	1986-10-14	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO167802C (no)	1991-12-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO871907D0 (no)	1987-05-07	Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO874780D0 (no)	1987-11-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO900972L (no)	1990-09-04	Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO900942D0 (no)	1990-02-28	Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724L (no)	1989-08-23	Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO166715C (no)	1991-08-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.